3Z5-55275-23027
3 vaccinations
7 coded responses
39 check-ins
7 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 010 / MA
- Registered
- 2021-03-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-30
Registered in v-safe
-
2021-03-30
Dose 1 — Pfizer-BioNTech
- 2021-03-30
-
2021-03-31
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-01
- 2021-04-02
- 2021-04-03
- 2021-04-04
- 2021-04-05
-
2021-04-06
Survey response — day 7, dose 1MedDRA: Eczema, Pre-existing disease — Feeling: Good · Rash, not including the immediate area around the injection siteFree text: Eczema flare upMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-13
-
2021-04-20
Dose 2 — Pfizer-BioNTech
-
2021-04-20
Health check-in — day 0, dose 2Feeling: Good · Site: Pain · None · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-21
Survey response — days 1–6 daily, dose 2MedDRA: Insomnia — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: Difficulty sleepingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-22
-
2021-04-23
Survey response — days 1–6 daily, dose 2MedDRA: Eczema, Pre-existing disease — Feeling: Good · Site: Pain, Itching · Fatigue or tiredness, Rash, not including the immediate area around the injection siteFree text: Eczema flare upMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-24
-
2021-04-25
Survey response — days 1–6 daily, dose 2MedDRA: Eczema — Feeling: Good · Rash, not including the immediate area around the injection siteFree text: Eczema flareupMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-26
Survey response — days 1–6 daily, dose 2MedDRA: Eczema, Pre-existing disease — Feeling: Good · Rash, not including the immediate area around the injection siteFree text: Eczema flare upMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-27
Survey response — day 7, dose 2MedDRA: Eczema, Pre-existing disease — Feeling: Good · Rash, not including the immediate area around the injection siteFree text: Eczema flare upMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-04
- 2021-05-11
- 2021-05-18
- 2021-05-25
- 2021-06-03
- 2021-07-20
- 2021-10-19
-
2021-11-12
Dose 3 — Moderna
-
2021-11-12
Health check-in — day 0, dose 3Feeling: Fair · Site: Pain · Headache · Be unable to do your normal daily activitiesAdult check-in
-
2021-11-13
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-11-14
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-11-15
- 2021-11-16
- 2021-11-17
- 2021-11-18
- 2021-11-19
- 2021-11-26
- 2021-12-03
- 2021-12-10
- 2021-12-17
- 2021-12-24
- 2022-02-11
-
2022-05-13
Survey response — 6 months, dose 3MedDRA: Influenza, Sialoadenitis — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Had the flu, soon after had a case of sialadenitis, unrelated to the vaccine!MedDRA releases: 2024-11 · check-in free text available
-
2022-05-13
Report sent to call center — 6 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-05-16
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-30 | Pfizer-BioNTech | |
| 2 | 2021-04-20 | Pfizer-BioNTech | |
| 3 | 2021-11-12 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-05-13 | Successful 2022-05-16 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 7 — day 7, dose 1
Systemic reaction (other): Eczema flare up
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Difficulty sleeping
Systemic reaction (other): Eczema flare up
Systemic reaction (other): Eczema flareup
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Eczema flare up
Release 8 — day 7, dose 2
Systemic reaction (other): Eczema flare up
Release 11 — 6 months, dose 3
Symptoms: Had the flu, soon after had a case of sialadenitis, unrelated to the vaccine!
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Influenza | · | · | ✓ |
| SD | Sialoadenitis | · | · | ✓ |
| SRO | Eczema | ✓ | ✓ | ✓ |
| SRO | Insomnia | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release